EcoDrugPlus

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSDNOG00000007108
Gene Symbol: IKBKB
4 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSDNOG00000005860
Gene Symbol: IMPDH1
2 Cross references
335 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSDNOG00000014105
Gene Symbol: IMPDH2
4 Cross references
202 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSDNOG00000003514
Gene Symbol: IGF1R
4 Cross references
276 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSDNOG00000048372
Gene Symbol: INSR
4 Cross references
290 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSDNOG00000008105
Gene Symbol: ITGA2B
4 Cross references
191 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSDNOG00000019241
Gene Symbol: ITGA4
2 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSDNOG00000019000
Gene Symbol: ITGA5
2 Cross references
267 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSDNOG00000000841
Gene Symbol: ITGAV
4 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSDNOG00000036774
Gene Symbol: ITGB1
2 Cross references
301 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSDNOG00000008290
Gene Symbol: ITGB3
4 Cross references
268 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSDNOG00000035121
Gene Symbol: ITGB5
2 Cross references
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).